Verisante Technology Inc. V.VRS

VRS vs MDX

[gaserx2]

In the past I have refrained from taking negative shots at management of VRS. Only on a few occasions. But I now wonder what gives with the team at VRS. So here I go with my negativity.

Why has MedX moved ahead faster than VRS in implimenting mole scanning technology into the market. They have placed according to some sources approximately 200 units [Sciascope] in the UK. Namely Boots Drug Stores whom are affiliated with Wahlgrens in the US.. As well units in Norway and Sweden. They say now they have their sites set on Canada with target locations in most provinces. Good Luck with that move.
But my point being MEDX supposedy has an inferior product as to VRS, yet they are making strides. So what gives with TB and our product. I hope they are monitoring this board and get some insight as to shareholder awareness as to what may be going on, because they really do need to post an update on their priority plans.
If they can't execute properly and quit being used by all these study groups such as the UK Brain Study [Charing Cross and NHS} and China, etc. Then they should put this technology and all its rights up for sale and bring some value to VRS so patient longs can get out of this disaster and put their money into something that actually has merit.
In all sincerity we do, I'm sure have a superior product to any competitor out there, but we just haven't executed somehow to the Medical Industry at large.
In summation though one factor helping MEDX is that they have FDA approval which definitely gives them an advantage to market.
So to the team at VRS it may be time to SH!T or get off the pot. 61/2 years is long enough. [Big rollout [Feb/2011] I think you have completed your test drive. IMHO